Donald Trump Could Reclassify Marijuana This Week: Details
The pot industry could incur a big change this week… The post Donald Trump Could Reclassify Marijuana This Week: Details appeared first on Reality Tea.
The Trump administration wants to reschedule marijuana. It’s not full legalization.
Rescheduling marijuana would not impact people incarcerated on marijuana charges, or fully legalize adult-use marijuana. This move specifically would allow medical research institutions to access …
5WPR Publishes the Cannabis Communications Gap Report, Documenting Why a $38.5 Billion Industry Operates with the Weakest Communications Infrastructure in American Business
WPR, one of the largest independent public relations and digital marketing firms in the United States, today published The Cannabis Communications Gap, a 2026 research report documenting the …
Federal cannabis reform has “the votes,” top Dem says (Newsletter: April 22, 2026)
Reject gov’s marijuana amendments; GOP bill links cannabis & health costs; USDA hemp report; Study: Youth use down after legalization Subscribe to receive Marijuana Moment’s newsletter in your inbox …
Ellsworth denies business license to cannabis chain for 2nd time
After being denied a business license in February, Frank Berenyi submitted a new license application under an abbreviated name, M-Ville.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Four stocks blazing higher as President Trump prepares another controversial executive order
Stocks of the leading marijuana companies are blazing higher today on reports that President Donald Trump could soon sign an executive order on pot’s legal status. Under the Trump administration’s …
Curaleaf and more cannabis stocks soar. A regulatory breakthrough is coming.
Cannabis stocks were surging following multiple reports that the Department of Justice could move forward with reclassifying the drug as soon as Wednesday. The initiative would shift cannabis from …
This 4/20, Wall Street is betting on more than marijuana
While many investors focused on the annual 4/20 holiday, expecting the usual buzz around marijuana stocks, a quiet revolution was unfolding in Washington. Over a weekend when most of the market was …
The 420 failure: Here’s the real reason Tilray Brands has been a horrible investment despite operating in a legal marijuana market
The cannabis stock has lost around 96% of its value over the past five years.
CBD Life Sciences Inc. (CBDL) Enters into Stock Purchase Agreement with FBC Holding Inc. to Acquire Mushroom Madness Inc. and Formrunner Apparel; Subsidiaries Now 100% Wholly Owned
SCOTTSDALE, AZ / ACCESS Newswire / April 22, 2026 /CBD Life Sciences Inc. (OTC:CBDL) CBD Life Sciences Inc. is proud to announce the successful execution of a stock purchase agreement with FBC Holding …
Roth Capital Highlights Discontinued CBD Products Weighing on FitLife Brands, Inc. (FTLF)
We recently compiled a list of the 10 Best Beaten Down Stocks to Invest in According to Analysts. FitLife Brands, Inc. is one of the best 52-week low stocks on our list. TheFly reported on April 6 …
Vantage Hemp Co. Engages ACOs and GPOs to Advance Participation in CMS CBD Pilot Program
Vantage Hemp Co. (“Vantage” or “the Company”), a cannabinoid manufacturer focused on pharmaceutical-grade production, announces active engagement with multiple Accountable Care Organizations (ACOs) …
Trumps FDA CBD Enforcement Shift Signals a Turning Point – Why MMJ International Holdings is the Sector’s Opportunity
Duane Boise CEO stated, “As cannabinoid policy shifts from retail access toward physician directed treatment and insurance participation, companies with IND programs, orphan-drug positioning, and bota …
High Tide’s NuLeaf Naturals Targets Role in New U.S. Medicare CBD Pilot
High Tide’s U.S. hemp-derived CBD subsidiary NuLeaf Naturals is moving to participate in a new U.S. Centers for Medicare & Medicaid Services Innovation Center pilot that allows certain …
Recent Comments